Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 1:36 pm Sale |
2022-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital LLC | 0 0.000% |
-2,759,505 (Position Closed) |
Filing History |
| 2023-02-14 1:22 pm Sale |
2022-12-31 | 13G | 2seventy bio, Inc. TSVT |
EcoR1 Capital LLC | 1,143,494 3.000% |
-773,569 (-40.35%) |
Filing History |
| 2023-02-14 1:03 pm Sale |
2022-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
EcoR1 Capital LLC | 497,349 9.100% |
-11,737 (-2.31%) |
Filing History |
| 2023-02-14 12:10 pm Purchase |
2022-04-29 | 13G | Tempest Therapeutics, Inc. TPST |
EcoR1 Capital LLC | 1,052,810 9.990% |
1,052,810 (New Position) |
Filing History |
| 2023-02-13 2:08 pm Sale |
2022-12-31 | 13G | Surface Oncology, Inc. SURF |
EcoR1 Capital LLC | 3,924,713 6.500% |
-728,287 (-15.65%) |
Filing History |
| 2023-02-13 1:55 pm Unchanged |
2022-12-31 | 13G | Arvinas, Inc. ARVN |
EcoR1 Capital LLC | 3,123,300 5.900% |
0 (Unchanged) |
Filing History |
| 2023-02-13 1:43 pm Purchase |
2022-12-31 | 13G | Xencor, Inc. XNCR |
EcoR1 Capital LLC | 5,282,516 8.800% |
376,410 (+7.67%) |
Filing History |
| 2023-02-13 08:25 am Purchase |
2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
EcoR1 Capital LLC | 157,934 9.900% |
29,402 (+22.88%) |
Filing History |
| 2023-02-10 2:28 pm Purchase |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
EcoR1 Capital LLC | 6,117,400 8.700% |
35,200 (+0.58%) |
Filing History |
| 2023-02-10 1:59 pm Sale |
2022-12-31 | 13G | Akouos, Inc. AKUS |
EcoR1 Capital LLC | 0 0.000% |
-1,975,984 (Position Closed) |
Filing History |
| 2023-02-10 1:56 pm Sale |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,418,068 7.600% |
-50,876 (-1.47%) |
Filing History |
| 2023-02-10 1:48 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 6,638,371 9.900% |
2,094,924 (+46.11%) |
Filing History |
| 2023-02-10 1:48 pm Sale |
2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
EcoR1 Capital LLC | 0 0.000% |
-6,319,232 (Position Closed) |
Filing History |
| 2023-02-10 1:37 pm Purchase |
2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,184,861 7.400% |
808,727 (+15.04%) |
Filing History |
| 2023-02-10 1:13 pm Sale |
2022-12-31 | 13G | Alector, Inc. ALEC |
EcoR1 Capital LLC | 4,056,548 4.900% |
-938,422 (-18.79%) |
Filing History |
| 2023-02-09 5:55 pm Sale |
2022-12-31 | 13G | Solid Biosciences Inc. SLDB |
EcoR1 Capital LLC | 0 0.000% |
-613,513 (Position Closed) |
Filing History |
| 2023-02-09 5:47 pm Sale |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
EcoR1 Capital LLC | 0 0.000% |
-1,975,611 (Position Closed) |
Filing History |
| 2023-02-09 5:42 pm Sale |
2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
EcoR1 Capital LLC | 0 0.000% |
-5,523,358 (Position Closed) |
Filing History |
| 2023-01-23 12:14 pm Purchase |
2023-01-10 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 4,478,050 5.000% |
199,981 (+4.67%) |
Filing History |
| 2023-01-20 5:32 pm Purchase |
2023-01-10 | 13G | Janux Therapeutics, Inc. JANX |
EcoR1 Capital LLC | 3,255,270 7.800% |
3,255,270 (New Position) |
Filing History |